MedGroup LT - Company finances
|
EUR
|
2020
From: 2020-06-12
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 739,681 | 2,110,616 | 4,110,880 | 9,416,849 | 13,348,711 | 15,335,187 |
| Profit before tax | 130,327 | 420,905 | 374,150 | 333,012 | 1,057,593 | 1,159,531 |
| Net profit | 110,778 | 357,769 | 318,027 | 279,797 | 888,213 | 945,361 |
| Equity | 113,778 | 471,548 | 786,574 | 1,069,371 | 1,957,584 | 2,902,945 |
| Liabilities | 505,024 | 345,867 | 2,000,681 | 4,453,675 | 5,821,890 | 7,153,038 |
| Non-current assets | 0 | 9,455 | 12,119 | 16,435 | 33,160 | 51,730 |
| Current assets | 618,802 | 807,960 | 2,775,136 | 5,506,611 | 7,746,178 | 9,988,641 |
| Total assets | 618,802 | 817,415 | 2,787,255 | 5,523,046 | 7,779,338 | 10,040,371 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 134,158 | 126,123 | 343,905 |
| Social insurance contributions | - | - | - | 53,479 | 111,368 | 146,804 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +185.3% | +94.8% | +129.1% | +41.8% | +14.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.9% | 43.8% | 11.4% | 5.1% | 11.4% | 9.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 97.4% | 75.9% | 40.4% | 26.2% | 45.4% | 32.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 15.0% | 17.0% | 7.7% | 3.0% | 6.7% | 6.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.6% | 19.9% | 9.1% | 3.5% | 7.9% | 7.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.4 | 0.7 | 2.5 | 4.2 | 3.0 | 2.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 739,681 | 1,948,321 | 1,006,754 | 1,189,492 | 1,033,446 | 958,449 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MedGroup LT - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-26 | 2026-09-02 | 14.75 |
| 2026-08-23 | 2026-08-23 | 14.75 |
| 2026-08-19 | 2026-08-19 | 14.75 |
| 2025-12-23 | 2025-12-28 | 0.10 |
| 2025-12-04 | 2025-12-11 | 0.08 |
| 2025-02-10 | 2025-02-10 | 20.87 |
| 2025-01-22 | 2025-01-28 | 20.87 |
| 2025-01-16 | 2025-01-21 | 20.75 |
| 2024-12-22 | 2024-12-31 | 20.75 |
| 2024-12-17 | 2024-12-20 | 20.75 |
| 2024-11-18 | 2024-11-28 | 10.67 |
| 2024-05-16 | 2024-05-28 | 24.15 |
| 2024-04-23 | 2024-05-13 | 25.09 |
| 2024-04-16 | 2024-04-22 | 0.01 |
| 2024-02-19 | 2024-02-29 | 23.71 |
| 2024-01-16 | 2024-01-28 | 5947.15 |
| 2023-11-16 | 2023-11-21 | 13.58 |
| 2023-10-25 | 2023-11-07 | 13.58 |
| 2023-08-17 | 2023-09-05 | 0.40 |
| 2023-07-28 | 2023-08-02 | 0.40 |
| 2023-07-26 | 2023-07-27 | 4259.43 |
| 2023-07-24 | 2023-07-25 | 4259.84 |
| 2023-07-18 | 2023-07-23 | 4259.43 |
| 2023-05-16 | 2023-05-30 | 86.18 |
| 2022-08-30 | 2022-08-31 | 1241.90 |
| 2022-08-23 | 2022-08-29 | 1317.69 |
| 2022-05-17 | 2022-06-06 | 18.65 |
| 2022-04-28 | 2022-05-05 | 18.65 |
| 2022-04-19 | 2022-04-27 | 18.44 |
MedGroup LT - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MedGroup LT, UAB (code 305572289) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €15.34M and net profit of €945.4K, corresponding to a profit margin of 6.2%. This continued a clear growth trend from €9.42M revenue and €279.8K net profit in 2023, to €13.35M revenue and €888.2K net profit in 2024. Over the two-year period, revenue increased by 62.9%. The balance sheet also expanded, with total assets rising from €5.52M in 2023 to €7.78M in 2024 and €10.04M in 2025, while equity increased from €1.07M to €1.96M and then to €2.90M. For 2025, the company reported an equity ratio of 28.9%, ROE of 32.6%, ROA of 9.4% and asset turnover of 1.53x. Revenue per employee reached €958.4K and profit per employee €59.1K, indicating strong productivity in the latest year.